Rhoen Klinikum AG (RHK) Receives €21.43 Average Price Target from Analysts

Shares of Rhoen Klinikum AG (ETR:RHK) have received an average rating of “Sell” from the seven research firms that are covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is €21.43 ($24.92).

A number of research firms have recently weighed in on RHK. Commerzbank set a €25.00 ($29.07) price target on shares of Rhoen Klinikum and gave the company a “neutral” rating in a research note on Friday, November 9th. Warburg Research set a €25.20 ($29.30) price target on shares of Rhoen Klinikum and gave the company a “neutral” rating in a research note on Friday, November 9th. Cfra set a €22.00 ($25.58) price target on shares of Rhoen Klinikum and gave the company a “sell” rating in a research note on Monday, November 12th. Credit Suisse Group set a €17.00 ($19.77) target price on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Wednesday, January 23rd. Finally, Independent Research set a €24.00 ($27.91) target price on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Tuesday, November 13th.

Shares of RHK traded up €0.02 ($0.02) during mid-day trading on Monday, reaching €23.00 ($26.74). The company had a trading volume of 15,492 shares, compared to its average volume of 43,281. Rhoen Klinikum has a 1-year low of €25.08 ($29.16) and a 1-year high of €32.12 ($37.35).

About Rhoen Klinikum

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Read More: How Do Tariffs Affect Trade Balances?

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit